Kytx deadline: kytx investors have opportunity to lead kyverna therapeutics, inc. securities lawsuit

New york , feb. 7, 2025 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, reminds purchasers of common stock of kyverna therapeutics, inc. (nasdaq: kytx) pursuant and/or traceable to kyverna's initial public offering conducted on february 8, 2024 (the "ipo"), of the important february 7, 2025 lead plaintiff deadline. so what: if you purchased kyverna common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
KYTX Ratings Summary
KYTX Quant Ranking